PHILADELPHIA--(BUSINESS WIRE)--Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in AAV gene therapy, is pleased to announce data presentations in support of its preclinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback